PIMA525629

DPP3 Monoclonal Antibody (OTI2D9), Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIMA525629-Each-of-1 In Stock ₹ 52,198.50

PIMA525629 - Each of 1

₹ 52,198.50

In Stock

Quantity

1

Base Price: ₹ 52,198.50

GST (18%): ₹ 9,395.73

Total Price: ₹ 61,594.23

Antigen

DPP3

Classification

Monoclonal

Concentration

0.58 mg/mL

Formulation

PBS with 1% BSA, 50% glycerol and 0.02% sodium azide; pH 7.3

Gene Accession No.

Q9NY33

Gene Symbols

DPP3

Immunogen

Full length human recombinant protein of DPP3 produced in HEK293 cell

Quantity

100μL

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG2b

Applications

Flow Cytometry, Immunohistochemistry (Paraffin), Western Blot

Clone

OTI2D9

Conjugate

Unconjugated

Gene

DPP3

Gene Alias

4930533O14Rik; C86324; Dipeptidyl aminopeptidase III; dipeptidyl arylamidase III; Dipeptidyl peptidase 3; dipeptidyl peptidase III; dipeptidylpeptidase 3; dipeptidyl-peptidase 3; dipeptidylpeptidase III; dipeptidyl-peptidase III; DPP III; Dpp3; DPPIII; Enkephalinase B; hCG_2016942

Host Species

Mouse

Purification Method

Affinity Chromatography

Regulatory Status

RUO

Gene ID (Entrez)

10072

Content And Storage

-20° C, Avoid Freeze/Thaw Cycles

Form

Liquid

Related Products

Img

Thermo Scientific

PIMA525638

--

Img

Thermo Scientific

PIMA525611

--

Img

Thermo Scientific

PIMA524927

--

Img

Thermo Scientific

PIMA525502

--

Img

Thermo Scientific

PIMA525500

--

Img

Thermo Scientific

PIMA525442

--

Img

Thermo Scientific

PIMA525157

--

Img

Thermo Scientific

PIMA525173

--

Description

  • This gene encodes a protein that is a member of the M49 family of metallopeptidases
  • This cytoplasmic protein binds a single zinc ion with its zinc-binding motif (HELLGH) and has post-proline dipeptidyl aminopeptidase activity, cleaving Xaa-Pro dipeptides from the N-termini of proteins
  • Increased activity of this protein is associated with endometrial and ovarian cancers
  • Alternate transcriptional splice variants have been characterized.